Breast
(Mar 2023)
P251 Real-world experience with CDK4/6 inhibitors for metastatic HR+/HER2−breast cancer at a single cancer center
- M. Milovic - Kovacevic,
- S. Bobic,
- A. Karaferic,
- L. Pavlovic,
- M. Matovic,
- B. Poparic - Bandjur
Affiliations
- M. Milovic - Kovacevic
- S. Bobic
- A. Karaferic
- L. Pavlovic
- M. Matovic
- B. Poparic - Bandjur
- Journal volume & issue
-
Vol. 68
p.
S115
WeChat QR code